Animal Drug Compounding Market - Global Industry Analysis

The global Animal Drug Compounding market accrued earnings worth approximately 1.21(USD Billion) in 2020 and is predicted to gain revenue of about 3.31(USD Billion) by 2028, is set to record a CAGR of nearly 6.5% over the period from 2021 to 2028. The report offers assessment and analysis of the Animal Drug Compounding market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).

Report Scope :

Animal Drug Compounding Market: Synopsis

Animal drug compounding is a process of mixing and changing ingredients for creating medicine tailored to requirements of a particular animal or a small animal group. These drugs play a major role in veterinary activities. Furthermore, animal compounded drugs are manufactured & licensed by either veterinarians or pharmacists. According to U.S. FDA, the federal food, drug, and cosmetic act allow animal drug compounding when active ingredient source is a finished FDA approved medicine and not a bulk material. Reportedly, on June 11 2020, the U.S. FDA has released revised draft guidance on animal drug compounding from bulk drug materials. This include (i) filling of patient-specific medical prescriptions by veterinarians & pharmacists for non-food manufacturing animals, (ii) compounding antidotes for food producing animals, and  (iii) compounding office stock from bulk drug materials for non-food producing animals.

Furthermore, when a pet gets ill and there is no apt medicine available for treating it, pharmacists or veterinarians prescribe drug formulation through animal drug compounding process. They depend on two key animal drug compounding methods including bulk ingredients and extra-label drugs. In bulk ingredients process, pharmacists compound new medicines by combining bulk ingredients with fillers, suspension solutions, and flavors. In case of extra-label drugs procedure, pharmacist makes use of FDA approved veterinary medicine and combines it with tablets & other ingredients for fulfilling medical needs of pet animal. 

Animal Drug Compounding Market: Growth Factors

Safe & effective drugs are a key for veterinarians for treating animals & pets. Moreover, a veterinarian drug approved by U.S. FDA is not always available to veterinary doctors for treating pets and in such situations veterinarians make use of compounded drugs for effectively treating animal conditions. Such moves & initiatives are anticipated to expedite growth of animal drug compounding market. Apparently, animal health sector aids usage of animal drug compounding activities for addressing medical requirements of animals, thereby embellishing growth of animal drug compounding market. Surge in demand for myriad animal anti-infective drugs & animal anti-inflammatory medicines like tramadol, metronidazole, and ketoconazole will create new growth avenues for animal drug compounding industry during forecast timespan.

Furthermore, key producers are trying to launch new products with different routes of administration including oral, ocular, topical, and injection. This, in turn, will translate into increase in market size during forthcoming years. Apparently, rise in demand for product across companion animal & livestock sector will drive industry trends. Breakthroughs in pharmaceutical industry will spearhead growth of animal drug computing market in foreseeable future.  

Regional Landscape

Europe To Make Notable Contributions Towards Global Market Size By 2028

The growth of animal drug compounding market in Europe Over 2021-2028 is due to massive production of animal drug compounding in countries such as Germany. In addition to this, escalating demand for anti-infectives and anti-inflammatories along with thriving pharma sector will drive regional market trends. Apart from this, favorable laws aiding use of customized animal drug compounding for treating pets in countries such as the UK, Italy, Russia, France, Belgium, Switzerland, and Germany will prompt growth of animal drug compounding business in Europe. Focus of players in continent for addressing medicine shortages will aid regional market growth.

Competitive Landscape

Key players influencing market growth and profiled in study are Wedgewood Pharmacy, Davis Islands Pharmacy, Millers Pharmacy, Wellness Pharmacy of      Cary, Smith’s Pharmacy, Central Compounding Center South, Caringbah Compounding Pharmacy, and Triangle Compounding Pharmacy.

The global Animal Drug Compounding Market is segmented as follows:

By Product

• Anti-Infectives
• Anti-Inflammatory
• GI Drugs
• CNS Agents

By Animal Type

• Companion Animal 
• Livestock Animal

By Dosage Form

• Capsule
• Powder
• Solution
• Suspension 

By Route of Administration

• Oral
• Injectables
• Ocular
• Topical
• Rectal

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

• Chapter 1.Preface
  • 1.1.Report Description and Scope
  • 1.2.Research Scope
  • 1.3.Research Methodology
    • 1.3.1.Market Research Type
    • 1.3.2.Market Research Methodology
• Chapter 2.Executive Summary
  • 2.1.Animal Drug Compounding Market, 2018–2028(USD Billion)
  • 2.2.Animal Drug Compounding Market: Snapshot
• Chapter 3.Global Animal Drug CompoundingMarket– Industry Analysis
  • 3.1.Animal Drug CompoundingMarket: Market Dynamics
  • 3.2.Market Drivers
    • 3.2.1. Safe & effective drugs are vital for veterinarians in treating animals & pets. Furthermore, a veterinarian medicine approved by U.S. FDA is not always accessible to veterinary physicians for treating pet animals and in these situations veterinarians apply compounded drugs for effectively treating animal conditions. Such moves will prop up expansion of animal drug compounding market.
    • 3.2.2.Animal health sector supports use of animal drug compounds for addressing healthcare requirements of animals, thereby inflating animal drug compounding industry size.
  • 3.3.Porter’s Five Forces Analysis
  • 3.4.Market Attractiveness Analysis
    • 3.4.1.Market attractiveness analysis By Product
    • 3.4.2.Market attractiveness analysis By Animal Type
    • 3.4.3.Market attractiveness analysis By Route of Administration
    • 3.4.4.Market attractiveness analysis By Dosage Form
• Chapter 4.Global Animal Drug CompoundingMarket– Competitive Landscape
  • 4.1.Company market share analysis
    • 4.1.1.Global Animal Drug CompoundingMarket: company market share, 2019
  • 4.2.Strategic development
    • 4.2.1.Acquisitions & mergers
    • 4.2.2.New Product launches
    • 4.2.3.Agreements, partnerships, cullaborations, and joint ventures
    • 4.2.4.Research and development and Regional expansion
  • 4.3.Price trend analysis
• Chapter 5.Global Animal Drug CompoundingMarket– Product Analysis
  • 5.1.Global Animal Drug CompoundingMarket overview: By Product
    • 5.1.1.Global Animal Drug CompoundingMarket share, By Product, 2020 and 2028
  • 5.2.Anti-Infectives
    • 5.2.1.Global Animal Drug CompoundingMarket by Anti-Infectives, 2018–2028(USD Billion)
  • 5.3.Anti-Inflammatory
    • 5.3.1.Global Animal Drug CompoundingMarket by Anti-Inflammatory, 2018–2028(USD Billion)
  • 5.4.GI Drugs
    • 5.4.1.Global Animal Drug CompoundingMarket by GI Drugs, 2018–2028(USD Billion)
  • 5.5.CNS Agents
    • 5.5.1.Global Animal Drug CompoundingMarket by CNS Agents, 2018–2028(USD Billion)
• Chapter 6.Global Animal Drug CompoundingMarket– Animal Type Analysis
  • 6.1.Global Animal Drug CompoundingMarket overview: By Animal Type
    • 6.1.1.Global Animal Drug CompoundingMarket share, By Animal Type, 2020 and 2028
  • 6.2.Companion Animal
    • 6.2.1.Global Animal Drug CompoundingMarket by Companion Animal , 2018–2028(USD Billion)
  • 6.3.Livestock Animal
    • 6.3.1.Global Animal Drug CompoundingMarket by Livestock Animal, 2018–2028(USD Billion)
• Chapter 7.Global Animal Drug CompoundingMarket– Route of Administration Analysis
  • 7.1.Global Animal Drug CompoundingMarket overview: By Route of Administration
    • 7.1.1.Global Animal Drug CompoundingMarket share, By Route of Administration, 2020 and 2028
  • 7.2.Oral
    • 7.2.1.Global Animal Drug CompoundingMarket by Oral , 2018–2028(USD Billion)
  • 7.3.Injectables
    • 7.3.1.Global Animal Drug CompoundingMarket by Injectables, 2018–2028(USD Billion)
  • 7.4.Ocular
    • 7.4.1.Global Animal Drug CompoundingMarket by Ocular, 2018–2028(USD Billion)
  • 7.5.Topical
    • 7.5.1.Global Animal Drug CompoundingMarket by Topical, 2018–2028(USD Billion)
  • 7.6.Rectal
    • 7.6.1.Global Animal Drug CompoundingMarket by Rectal, 2018–2028(USD Billion)
• Chapter 8.Global Animal Drug CompoundingMarket overview: By Dosage Form
  • 8.1.Global Animal Drug CompoundingMarket share, By Dosage Form, 2020 and 2028
  • 8.2.Capsule
    • 8.2.1.Global Animal Drug CompoundingMarket by Capsule , 2018–2028(USD Billion)
  • 8.3.Powder
    • 8.3.1.Global Animal Drug CompoundingMarket by Powder, 2018–2028(USD Billion)
  • 8.4.Sulution
    • 8.4.1.Global Animal Drug CompoundingMarket by Sulution, 2018–2028(USD Billion)
  • 8.5.Suspension
    • 8.5.1.Global Animal Drug CompoundingMarket by Suspension, 2018–2028(USD Billion)
• Chapter 9.Company Profiles
  • 9.1.Wedgewood Pharmacy
    • 9.1.1.Overview
    • 9.1.2.Financials
    • 9.1.3.Product Portfolio
    • 9.1.4.Business Strategy
    • 9.1.5.Recent Developments
  • 9.2.Davis Islands Pharmacy
    • 9.2.1.Overview
    • 9.2.2.Financials
    • 9.2.3.Product Portfolio
    • 9.2.4.Business Strategy
    • 9.2.5.Recent Developments
  • 9.3.Millers Pharmacy
    • 9.3.1.Overview
    • 9.3.2.Financials
    • 9.3.3.Product Portfolio
    • 9.3.4.Business Strategy
    • 9.3.5.Recent Development
  • 9.4.Wellness Pharmacy of Cary
    • 9.4.1.Overview
    • 9.4.2.Financials
    • 9.4.3.Product Portfolio
    • 9.4.4.Business Strategy
    • 9.4.5.Recent Development
  • 9.5.Smith’s Pharmacy
    • 9.5.1. Overview
    • 9.5.2.Financials
    • 9.5.3.Product Portfolio
    • 9.5.4.Business Strategy
    • 9.5.5.Recent Development
  • 9.6.Central Compounding Center South
    • 9.6.1.Overview
    • 9.6.2.Financials
    • 9.6.3. Product Portfolio
    • 9.6.4.Business Strategy
    • 9.6.5.Recent Development
  • 9.7.Caringbah Compounding Pharmacy
    • 9.7.1.Overview
    • 9.7.2.Financials
    • 9.7.3.Product Portfolio
    • 9.7.4.Business Strategy
    • 9.7.5.Recent Development
  • 9.8.Triangle Compounding Pharmacy
    • 9.8.1. Overview
    • 9.8.2.Financials
    • 9.8.3.Product Portfolio
    • 9.8.4.Business Strategy
    • 9.8.5.Recent Development

Table Of Figures

List of Figures

1.Market research Type
2.Market research methodology
3.Global Animal Drug CompoundingMarket, 2018–2028(USD Billion)
4.Porter’s Five Forces Analysis
5.Global Animal Drug CompoundingMarketattractiveness, By Product
6.Global Animal Drug CompoundingMarketattractiveness, By Route of Administration
7.Global Animal Drug CompoundingMarketattractiveness, By Animal Type
8.Global Animal Drug CompoundingMarketattractiveness, By Dosage Form
9.Global Animal Drug CompoundingMarketshare by Product ,2020 and 2028 (USD Billion)
10.Global Animal Drug CompoundingMarketby Anti-Infectives, 2018–2028(USD Billion)
11.Global Animal Drug CompoundingMarketby Anti-Inflammatory, 2018–2028(USD Billion)
12.Global Animal Drug CompoundingMarketby GI Drugs, 2018–2028(USD Billion)
13.Global Animal Drug CompoundingMarketby CNS Agents, 2018–2028(USD Billion)
14.Global Animal Drug CompoundingMarketshare by Animal Type ,2020 and 2028 (USD Billion)
15.Global Animal Drug CompoundingMarketby Companion Animal  , 2018–2028(USD Billion)
16.Global Animal Drug CompoundingMarketby Livestock Animal, 2018–2028(USD Billion)
17.Global Animal Drug CompoundingMarketshare by Route of Administration ,2020 and 2028 (USD Billion)
18.Global Animal Drug CompoundingMarketby Oral,  2018–2028(USD Billion)
19.Global Animal Drug CompoundingMarketby Injectables, 2018–2028(USD Billion)
20.Global Animal Drug CompoundingMarketby Ocular, 2018–2028(USD Billion)
21.Global Animal Drug CompoundingMarketby Topical,  2018–2028(USD Billion)
22.Global Animal Drug CompoundingMarketby Rectal, , 2018–2028(USD Billion)
23.Global Animal Drug CompoundingMarketshare by Route of Administration ,2020 and 2028 (USD Billion)
24.Global Animal Drug CompoundingMarketby Capsule,  2018–2028(USD Billion)
25.Global Animal Drug CompoundingMarketby Solution, 2018–2028(USD Billion)
26.Global Animal Drug CompoundingMarketby Suspension, 2018–2028(USD Billion)
27.Global Animal Drug CompoundingMarketby Powder, 2018–2028(USD Billion)
28.Global Animal Drug CompoundingMarketshare, by Region, 2020 and 2028
29.North America Animal Drug CompoundingMarket, 2018–2028(USD Billion)
30.Europe Animal Drug CompoundingMarket, 2018–2028(USD Billion)
31.Asia Pacific Animal Drug CompoundingMarket, 2018–2028(USD Billion)
32.Latin America Animal Drug CompoundingMarket, 2018–2028(USD Billion)
33.The Middle East and Africa Animal Drug CompoundingMarket, 2018–2028(USD Billion)
 

Table Of Tables

List of Tables

1.Global Animal Drug CompoundingMarket: snapshot
2.Drivers of the Animal Drug CompoundingMarket: impact analysis
3.North America Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
4.North America Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
5.North America Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
6.North America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
7.The U.S. Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
8.The U.S. Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
9.The U.S. Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
10.The U.S. Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
11.Rest of North America Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
12.Rest of North America Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
13.Rest of North America Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
14.Rest of North America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
15.Europe Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
16.Europe Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
17.Europe Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
18.Europe Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
19.UK Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
20.UK Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
21.UK Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
22.UK Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
23.France Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
24.France Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
25.France Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
26.France Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
27.Germany Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
28.Germany Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
29.Germany Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
30.Germany Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
31.Rest of Europe Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
32.Rest of Europe Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
33.Rest of Europe Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
34.Rest of Europe Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
35.Asia Pacific Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
36.Asia Pacific Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
37.Asia Pacific Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
38.Asia Pacific Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
39.China Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
40.China Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
41.China Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
42.China Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
43.Japan Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
44.Japan Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
45.Japan Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
46.Japan Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
47.India Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
48.India Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
49.India Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
50.India Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
51.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
52.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
53.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
54.Rest of Asia Pacific Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
55.Latin America Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
56.Latin America Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
57.Latin America Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
58.Latin America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
59.Brazil Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
60.Brazil Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
61.Brazil Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
62.Brazil Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
63.Rest of Latin America Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
64.Rest of Latin  America Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
65.Rest of Latin America Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
66.Rest of Latin  America Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
67.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
68.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
69.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
70.The Middle East and Africa Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
71.Saudi Arabia Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
72.Saudi Arabia Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
73.Saudi Arabia Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
74.Saudi Arabia Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
75.South Africa Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
76.South Africa Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
77.South Africa Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
78.South Africa Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)
79.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Product  ,2018–2028(USD Billion)
80.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Animal Type  ,2018–2028(USD Billion)
81.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Route of Administration  ,2018–2028(USD Billion)
82.Rest of the Middle East & Africa Animal Drug CompoundingMarket revenue, By Dosage Form ,2018–2028(USD Billion)